258 related articles for article (PubMed ID: 28717884)
1. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
[TBL] [Abstract][Full Text] [Related]
3. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
[TBL] [Abstract][Full Text] [Related]
5. Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
Baumgarten P; Quick-Weller J; Gessler F; Wagner M; Tichy J; Forster MT; Foerch C; Seifert V; Mittelbronn M; Senft C
J Neurooncol; 2018 Sep; 139(3):541-546. PubMed ID: 29797180
[TBL] [Abstract][Full Text] [Related]
6. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.
Bennett IE; Guo H; Kountouri N; D'abaco GM; Hovens CM; Moffat BA; Desmond P; Drummond K; Kaye AH; Morokoff AP
J Clin Neurosci; 2015 Nov; 22(11):1802-8. PubMed ID: 26308396
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers for glioblastoma multiforme.
Quddusi A; Shamim MS
J Pak Med Assoc; 2019 Jun; 69(6):913-914. PubMed ID: 31201406
[TBL] [Abstract][Full Text] [Related]
8. Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors.
Lyubimova NV; Timofeev YS; Mitrofanov AA; Bekyashev AK; Goncharova ZA; Kushlinskii NE
Bull Exp Biol Med; 2020 Feb; 168(4):503-506. PubMed ID: 32147765
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
[TBL] [Abstract][Full Text] [Related]
11. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
[TBL] [Abstract][Full Text] [Related]
12. High plasma-GFAP levels in metastatic myxopapillary ependymoma.
Ilhan-Mutlu A; Berghoff AS; Furtner J; Dieckmann K; Slavc I; Czech T; Marosi C; Wagner L; Preusser M
J Neurooncol; 2013 Jul; 113(3):359-63. PubMed ID: 23624779
[TBL] [Abstract][Full Text] [Related]
13. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
[TBL] [Abstract][Full Text] [Related]
16. Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas.
Husain H; Savage W; Grossman SA; Ye X; Burger PC; Everett A; Bettegowda C; Diaz LA; Blair C; Romans KE; Holdhoff M
J Neurooncol; 2012 Aug; 109(1):123-7. PubMed ID: 22492246
[TBL] [Abstract][Full Text] [Related]
17. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
18. [Neuregulin 2 is highly expressed in glioma tissues to regulate glial fibrillary acidic protein expression
Zhao W; Lin J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1171-1176. PubMed ID: 34549707
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation.
Helwig K; Seeger F; Hölschermann H; Lischke V; Gerriets T; Niessner M; Foerch C
Neurocrit Care; 2017 Aug; 27(1):68-74. PubMed ID: 28054291
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery.
Cata JP; Bhavsar S; Hagan KB; Arunkumar R; Grasu R; Dang A; Carlson R; Arnold B; Popat K; Rao G; Potylchansky Y; Lipski I; Ratty S; Nguyen AT; McHugh T; Feng L; Rahlfs TF
J Clin Neurosci; 2017 Sep; 43():224-228. PubMed ID: 28601568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
